Shade Rodriguez
Overview
Explore the profile of Shade Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nageli M, Rodriguez S, Manson A, Earl A, Brennan-Krohn T
bioRxiv
. 2024 Oct;
PMID: 39386481
Avibactam (AVI) is a diazabicyclooctane (DBO) β-lactamase inhibitor used clinically in combination with ceftazidime. At concentrations higher than those typically achieved , it also has broad-spectrum direct antibacterial activity against...
2.
Shukla A, Rodriguez S, Brennan-Krohn T
J Antimicrob Chemother
. 2024 Sep;
79(11):2867-2876.
PMID: 39224940
Background: Burkholderia cepacia complex (Bcc) is a collection of intrinsically drug-resistant Gram-negative bacteria that cause life-threatening disease in people with cystic fibrosis (CF). Standard antimicrobial susceptibility testing methods have poor...
3.
Morgan C, Kang Y, Green A, Smith K, Dowgiallo M, Miller B, et al.
PLoS Biol
. 2023 May;
21(5):e3002091.
PMID: 37192172
The streptothricin natural product mixture (also known as nourseothricin) was discovered in the early 1940s, generating intense initial interest because of excellent gram-negative activity. Here, we establish the activity spectrum...
4.
Cao Y, Rudrakshala J, Williams R, Rodriguez S, Sorkhdini P, Yang A, et al.
Am J Respir Cell Mol Biol
. 2022 May;
67(2):201-214.
PMID: 35585756
Idiopathic pulmonary fibrosis (IPF) is a particularly deadly form of pulmonary fibrosis of unknown cause. In patients with IPF, high serum and lung concentrations of CHI3L1 (chitinase 3 like 1)...
5.
Brennan-Krohn T, Grote A, Rodriguez S, Kirby J, Earl A
Antimicrob Agents Chemother
. 2022 Jan;
66(3):e0196921.
PMID: 35041511
Multidrug-resistant Gram-negative bacteria are a rapidly growing public health threat, and the development of novel antimicrobials has failed to keep pace with their emergence. Synergistic combinations of individually ineffective drugs...
6.
Smith K, Cheng A, Chopelas A, Dubois-Coyne S, Mezghani I, Rodriguez S, et al.
medRxiv
. 2020 Jun;
PMID: 32511593
The COVID-19 pandemic has severely disrupted worldwide supplies of viral transport media (VTM) due to widespread demand for SARS-CoV-2 RT-PCR testing. In response to this ongoing shortage, we began production...
7.
Smith K, Cheng A, Chopelas A, Dubois-Coyne S, Mezghani I, Rodriguez S, et al.
J Clin Microbiol
. 2020 May;
58(8).
PMID: 32404481
The COVID-19 pandemic has severely disrupted worldwide supplies of viral transport media (VTM) due to widespread demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-PCR (RT-PCR) testing. In...